The estimated Net Worth of Randoll Sze is at least 944 千$ dollars as of 10 September 2020. Mr. Sze owns over 1,000 units of Athenex Inc stock worth over 1,200$ and over the last 6 years he sold ATNX stock worth over 0$. In addition, he makes 942,989$ as Chief Financial Officer at Athenex Inc.
Randoll has made over 6 trades of the Athenex Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of ATNX stock worth 11,400$ on 10 September 2020.
The largest trade he's ever made was buying 1,000 units of Athenex Inc stock on 10 September 2020 worth over 11,400$. On average, Randoll trades about 667 units every 74 days since 2018. As of 10 September 2020 he still owns at least 6,000 units of Athenex Inc stock.
You can see the complete history of Mr. Sze stock trades at the bottom of the page.
Randoll Sze is Chief Financial Officer of the company. Prior to his appointment and since October 2017, Mr. Sze served as our Director of Corporate Development and Investor Relations, Asia Pacific. Prior to joining us, Mr. Sze began his career at Credit Suisse (Hong Kong) Limited (“Credit Suisse”) in 2006, and was most recently a Director in its Investment Banking and Capital Markets Division in Hong Kong, a position he held from January 2016 to September 2017. While at Credit Suisse, Mr. Sze worked primarily on financing and strategic advisory transactions for both private and public companies. Mr. Sze obtained a B.S. from University of California, Berkeley, and an M.S. degree from Columbia University.
As the Chief Financial Officer of Athenex Inc, the total compensation of Randoll Sze at Athenex Inc is 942,989$. There are 3 executives at Athenex Inc getting paid more, with Johnson Lau having the highest compensation of 4,483,840$.
Randoll Sze is 39, he's been the Chief Financial Officer of Athenex Inc since 2018. There are 17 older and no younger executives at Athenex Inc. The oldest executive at Athenex Inc is John Vierling, 74, who is the Independent Director.
Randoll's mailing address filed with the SEC is C/O ATHENEX, INC., 1001 MAIN STREET, SUITE 600, BUFFALO, NY, 14203.
Over the last 7 years, insiders at Athenex Inc have traded over 33,215,399$ worth of Athenex Inc stock and bought 5,920,005 units worth 73,651,360$ . The most active insiders traders include Advisors Llcperceptive Life...、Song Yi Zhang、Song Yi Mandra Medical Ltd .... On average, Athenex Inc executives and independent directors trade stock every 12 days with the average trade being worth of 10,843$. The most recent stock trade was executed by Joe Annoni on 22 February 2023, trading 625 units of ATNX stock currently worth 125$.
athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. the company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients. our business includes medical technology innovation centers and a unique manufacturing supply chain across both china and north america. through the connected innovation and manufacturing supply chain presence, we can identify, develop and deliver proprietary medical technology across continents and multiple regulatory environments.
Athenex Inc executives and other stock owners filed with the SEC include: